在B细胞中强大的构成性NF-κB信号驱动SLL/CLL类淋巴发育并克服微环境依赖
Valeria Soberón1,2,3,4, Lena Osswald1,2,5, Andrew Moore6,7
1Institute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Leukemia
|January 16, 2026
概括
核因子kappa B (NF-κB) 信号的构成性激活驱动小鼠淋巴瘤的发展. 这种信号通路还可以减少淋巴瘤的发生.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 异常的核因子kappa B (NF-κB) 激活是人类淋巴瘤的一个关键特征.
- NF-κB激活通常发生在卡帕B激酶2 (IKK2) 抑制剂的上游,影响多个信号通路.
研究的目的:
- 调查正规NF-κB信号传递,特别是通过IKK2在驱动淋巴发育中的作用.
- 确定不同水平的IKK2信号如何影响淋巴瘤的发展和特征.
- 阐明NF-κB激活影响淋巴瘤细胞行为和微环境依赖的机制.
主要方法:
- 在不同拷贝数的小鼠B细胞中诱导了构成性活跃的IKK2变异表达.
- 分析了淋巴发育,B细胞表型和B细胞受体克隆性.
- 评估了与TCL1过度表达和微环境依赖性的协同效应.
主要成果:
- 观察到剂量依赖的淋巴发育,强烈的IKK2信号导致统一的小淋巴细胞淋巴瘤 (SLL) /慢性淋巴细胞白血病 (CLL) 类恶性瘤.
- 中间IKK2信号导致了更异质的瘤.
- 构成性IKK2信号赋予了B1a细胞的竞争优势,与TCL1协同作用,并减少了微环境依赖.
结论:
- 佳能NF-κB信号传递作为淋巴瘤中强大的瘤驱动因素.
- 减少对微环境的依赖是通过淋巴瘤中NF-κB激活的关键机制.
- 这些发现强调了在淋巴瘤治疗中准NF-κB通路的治疗潜力.
相关概念视频
NF-κB-dependent Signaling Pathway
9.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.8K
B Cell Activation and Differentiation
16.1K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
16.1K
The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K
T Cell Activation and Clonal Selection
14.8K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.8K
Cells of the Adaptive Immune Response
8.5K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
8.5K
Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K


